Page last updated: 2024-08-18

cyclohexanol and Cystitis, Interstitial

cyclohexanol has been researched along with Cystitis, Interstitial in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	5 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Katafigiotis, I; Mykoniatis, I; Sfoungaristos, S; Yutkin, V	1
Dmochowski, R; Hanno, P; Moldwin, R; Nickel, JC; Payne, C; Peters, KM; Wein, A	1
Davis, E; Egerdie, B; Evans, R; Mackenzie, L; Nickel, JC; Shrewsbury, SB	1
Sidaway, P	1
Jhang, JF; Kuo, HC	1

Reviews

2 review(s) available for cyclohexanol and Cystitis, Interstitial

Article	Year
Immunotherapy options for painful bladder syndrome: what's the potential? Expert opinion on biological therapy, 2017, Volume: 17, Issue:12 Topics: Adalimumab; Antibodies, Monoclonal; BCG Vaccine; Cyclohexanols; Cystitis, Interstitial; Humans; Immunotherapy; Indans; Nerve Growth Factor; Tumor Necrosis Factor-alpha	2017
Bladder dysfunction in 2016: New insights into interstitial cystitis and chronic pelvic pain syndromes. Nature reviews. Urology, 2017, Volume: 14, Issue:2 Topics: Chronic Pain; Cyclohexanols; Cystitis, Interstitial; Humans; Indans; Pelvic Pain; Urinary Bladder; Urinary Bladder Diseases	2017

Trials

2 trial(s) available for cyclohexanol and Cystitis, Interstitial

Article	Year
Targeting the SHIP1 Pathway Fails to Show Treatment Benefit in Interstitial Cystitis/Bladder Pain Syndrome: Lessons Learned from Evaluating Potentially Effective Therapies in This Enigmatic Syndrome. The Journal of urology, 2019, Volume: 202, Issue:2 Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Cyclohexanols; Cystitis, Interstitial; Double-Blind Method; Female; Humans; Indans; Male; Middle Aged; Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases; Treatment Outcome; Young Adult	2019
A Phase II Study of the Efficacy and Safety of the Novel Oral SHIP1 Activator AQX-1125 in Subjects with Moderate to Severe Interstitial Cystitis/Bladder Pain Syndrome. The Journal of urology, 2016, Volume: 196, Issue:3 Topics: Administration, Oral; Adolescent; Adult; Aged; Cyclohexanols; Cystitis, Interstitial; Cystoscopy; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Indans; Male; Middle Aged; Pain Measurement; Pelvic Pain; Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases; Retrospective Studies; Syndrome; Time Factors; Treatment Outcome; Urinary Bladder; Young Adult	2016

Article

Year

Targeting the SHIP1 Pathway Fails to Show Treatment Benefit in Interstitial Cystitis/Bladder Pain Syndrome: Lessons Learned from Evaluating Potentially Effective Therapies in This Enigmatic Syndrome.

The Journal of urology, 2019, Volume: 202, Issue:2

Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Cyclohexanols; Cystitis, Interstitial; Double-Blind Method; Female; Humans; Indans; Male; Middle Aged; Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases; Treatment Outcome; Young Adult

2019

A Phase II Study of the Efficacy and Safety of the Novel Oral SHIP1 Activator AQX-1125 in Subjects with Moderate to Severe Interstitial Cystitis/Bladder Pain Syndrome.

The Journal of urology, 2016, Volume: 196, Issue:3

Topics: Administration, Oral; Adolescent; Adult; Aged; Cyclohexanols; Cystitis, Interstitial; Cystoscopy; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Indans; Male; Middle Aged; Pain Measurement; Pelvic Pain; Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases; Retrospective Studies; Syndrome; Time Factors; Treatment Outcome; Urinary Bladder; Young Adult

2016

Other Studies

1 other study(ies) available for cyclohexanol and Cystitis, Interstitial

Article	Year
Pain: SHIP-1 activation for IC/BPS? Nature reviews. Urology, 2016, Volume: 13, Issue:5 Topics: Cyclohexanols; Cystitis, Interstitial; Humans; Indans; Pain; Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases	2016